A detailed history of Borer Denton & Associates, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Borer Denton & Associates, Inc. holds 78,253 shares of ABT stock, worth $9.22 Million. This represents 3.04% of its overall portfolio holdings.

Number of Shares
78,253
Previous 76,883 1.78%
Holding current value
$9.22 Million
Previous $7.99 Billion 11.68%
% of portfolio
3.04%
Previous 2.9%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $137,095 - $161,838
1,370 Added 1.78%
78,253 $8.92 Billion
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $172,248 - $192,272
-1,710 Reduced 2.18%
76,883 $7.99 Billion
Q1 2024

Apr 25, 2024

BUY
$109.52 - $120.96 $44,355 - $48,988
405 Added 0.52%
78,593 $8.93 Billion
Q4 2023

Feb 13, 2024

BUY
$90.19 - $110.4 $4,599 - $5,630
51 Added 0.07%
78,188 $8.61 Billion
Q3 2023

Oct 20, 2023

BUY
$95.53 - $114.62 $11,845 - $14,212
124 Added 0.16%
78,137 $7.57 Billion
Q2 2023

Oct 19, 2023

BUY
$100.78 - $112.29 $7,558 - $8,421
75 Added 0.1%
78,013 $8.5 Billion
Q1 2023

Oct 19, 2023

BUY
$96.86 - $114.01 $322,253 - $379,311
3,327 Added 4.46%
77,938 $7.89 Billion
Q4 2022

Oct 19, 2023

BUY
$95.06 - $111.52 $28,042 - $32,898
295 Added 0.4%
74,611 $8.19 Billion
Q3 2022

Oct 19, 2023

BUY
$96.76 - $112.03 $276,540 - $320,181
2,858 Added 4.0%
74,316 $7.19 Billion
Q2 2022

Oct 19, 2023

BUY
$102.07 - $123.37 $18,168 - $21,959
178 Added 0.25%
71,458 $7.76 Billion
Q1 2022

Oct 19, 2023

BUY
$114.02 - $139.04 $8.13 Million - $9.91 Million
71,280 New
71,280 $8.44 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Borer Denton & Associates, Inc. Portfolio

Follow Borer Denton & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Borer Denton & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Borer Denton & Associates, Inc. with notifications on news.